Sports

Andrews Research & Education Foundation and Vector Science Announce Peptide Collaboration

· GlobeWire Daily Sports Desk · Source: www.prnewswire.com

2 min read

Key takeawaysThe Andrews Research & Education Foundation (AREF) and Vector Science and Therapeutics have announced a collaboration to evaluate and develop peptides for sports medicine and regenerative medicine applications.
Andrews Research & Education Foundation and Vector Science Announce Peptide Collaboration

Original GlobeWire Daily editorial illustration — not an event photograph.

The Andrews Research & Education Foundation (AREF) and Vector Science and Therapeutics have announced a collaboration to evaluate and develop peptides for sports medicine and regenerative medicine applications.

Dr. James Andrews, orthopedic surgeon and founder of AREF, alongside former U.S. Secretary of Health and Human Services and Vector Chairman Tommy G. Thompson, announced the partnership. The initiative aims to bring evidence-based research and clinical evaluation to musculoskeletal applications of peptides.

Partnership Overview

  • Research and Formulation: AREF will contribute intellectual property and bench-top research from Gulf Breeze, Florida, while Vector will formulate, supply, and test peptides using current good manufacturing practice (cGMP) standards at its Mequon, Wisconsin facility.
  • Clinical Programs: The collaboration will design clinical programs to assess soft tissue repair acceleration, muscle regeneration support for aging athletes, and degenerative osteoarthritis mitigation.
  • Physician Education: AREF and Vector plan to develop educational programs, courses, and symposia focused on peptide best practices and protocols for sports medicine fellows and residents.

Intellectual Property and Commercialization

Intellectual property resulting from the collaboration—including new peptides and medical applications—will be jointly owned by AREF and Vector. Vector will lead the commercialization of new products aligned with its direct-to-physician marketing activities.

Practical Implications and Verification

The collaboration is intended to generate scientific and clinical evidence for investigational peptides. Interested parties can review official announcements and disclosures through Vector Science and Therapeutics' profile on SEDAR+ or visit the official company website for further details.

Share this article

About the author

GlobeWire Daily Sports Desk — AI-assisted news based on attributed published sources.

More to read